Repligen RGEN
$163.81 −$6.48 (-3.81%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $163.81 0.00%
Open$169.61
Prev close$170.29
Day range$162.47 – $169.61
Volume697.7K
Market cap$10.47B
P/E (TTM)–
Dividend yield–
Earnings
Average move on report day±6.1%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+17.9%
Worst reaction-5.9%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 27 Oct 2026 | Pre Market | ±12.6% | -2.43% | Within range |
| 2026/Q2 | 28 Jul 2026 | Pre Market | ±11.7% | +10.90% | Within range |
| 2026/Q1 | 5 May 2026 | Pre Market | ±10.4% | +6.26% | Within range |
| 2025/Q4 | 24 Feb 2026 | Pre Market | ±11.4% | -0.54% | Within range |
| 2025/Q3 | 28 Oct 2025 | Pre Market | ±10.5% | -5.92% | Within range |
| 2025/Q2 | 29 Jul 2025 | Pre Market | ±11.3% | +4.72% | Within range |
| 2025/Q1 | 29 Apr 2025 | Pre Market | ±17.5% | -2.92% | Within range |
| 2024/Q4 | 20 Feb 2025 | Pre Market | ±10.1% | +7.92% | Within range |
| 2024/Q3 | 12 Nov 2024 | Pre Market | ±12.7% | +6.51% | Within range |
| 2024/Q2 | 30 Jul 2024 | Pre Market | ±12.3% | +16.37% | Bigger than priced |
| 2024/Q1 | 1 May 2024 | Pre Market | ±10.9% | -3.56% | Within range |
| 2023/Q4 | 21 Feb 2024 | Pre Market | ±10.5% | -2.82% | Within range |
| 2023/Q3 | 31 Oct 2023 | Pre Market | ±14.0% | +17.86% | Bigger than priced |
| 2023/Q2 | 2 Aug 2023 | Pre Market | ±11.7% | +2.01% | Within range |
| 2023/Q1 | 2 May 2023 | Pre Market | ±12.4% | +2.40% | Within range |
| 2022/Q4 | 22 Feb 2023 | Pre Market | ±14.3% | -4.51% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q3
By business line
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$209.31M+10.9% YoY
Operating profit$12.96M+2.2% YoY
Net profit-$38.43M-357.7% YoY
Diluted EPS-$0.68-361.5% YoY
Free cash flow$37.82M-11.5% YoY
Operating cash flow$43.10M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin53.5%
Operating margin7.6%
Net margin-1.5%
Return on equity-0.6%
Return on assets-0.4%
Return on invested capital0.1%
Current ratio9.88
Liabilities / assets28.5%
Cash & investments$862.98M
Total debt$671.84M
Net cash (debt)$191.14M
Free cash flow / sales13.1%
No comments yet — be the first to weigh in on RGEN.
Sign in to join the discussion.